CNS demyelination during anti–tumor necrosis factor alpha therapy
LETTER TO THE EDITORS
First Online:
Received:
Revised:
Accepted:
- 142 Downloads
- 21 Citations
Keywords
Multiple Sclerosis Infliximab Etanercept Adalimumab Multiple Sclerosis Study Group
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717–1725PubMedCrossRefGoogle Scholar
- 2.Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 334:907–916CrossRefGoogle Scholar
- 3.Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in muliple sclerosis brain. J Exp Med 170:607–612PubMedCrossRefGoogle Scholar
- 4.Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041–1045PubMedGoogle Scholar
- 5.Maimone D, Gregory S, Arnason BGW, Reder AT (1991) Citokine levels in the cerebrospinal fluid and serum of patient with multiple sclerosis. J Neuroimmunol 32:67–74PubMedCrossRefGoogle Scholar
- 6.Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350:2167–2179PubMedCrossRefGoogle Scholar
- 7.TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept MS study group and The University of British Columbia MS/MRI Analysis Group (1999). Neurology 53:457–465Google Scholar
- 8.Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p-75)-Fc fusion protein. N Eng J Med 337:141–147CrossRefGoogle Scholar
- 9.Selmaj KW, Raine CS (1995) Experimental autoimmune encephalomyelitis: immunotherapy with antitumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45(Suppl 6):S44–S49PubMedGoogle Scholar
- 10.Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti- TNF therapy. Neurology 57:1885–1888PubMedGoogle Scholar
- 11.Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthrides. Arthritis Rheum 44:2862–2869PubMedCrossRefGoogle Scholar
Copyright information
© Steinkopff-Verlag 2006